Posted by Michael Wonder on 29 Feb 2024
New Zealand Pharmaceutical Schedule - 1 March 2024
1 March 2024 - The March 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.
There are two new listings of note this month:
- Meningococcal Group B vaccine (multicomponent) (Bexsero) - restriction change
- Varicella zoster virus vaccine (adjuvanted) (Shingrix) - new vaccine
- Sacubitril with valsartan (Entresto) - restriction change
- Nivolumab (Opdivo) - restriction change
- Pembrolizumab (Keytruda) - restriction change
Read New Zealand Pharmaceutical Schedule update
Posted by:
Michael Wonder